Related Experiment Video
Updated: Mar 17, 2026

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
Total Arterial Revascularization: A Superior Strategy for Diabetic Patients Who Require Coronary Surgery
James Tatoulis1, Rochelle Wynne2, Peter D Skillington1
1Department of Cardiothoracic Surgery, Royal Melbourne Hospital, Melbourne, Australia; Department of Surgery, University of Melbourne, Melbourne, Australia.
Insights
Total arterial revascularization (TAR) offers diabetic patients undergoing coronary artery bypass graft surgery (CABG) improved long-term survival. This approach showed a survival advantage for diabetic patients with no increase in perioperative mortality.
Area of Science:
- Cardiovascular Surgery
- Diabetic Cardiopathy
- Surgical Outcomes
Background:
- Coronary artery bypass graft surgery (CABG) is superior to percutaneous intervention for diabetic patients with advanced coronary artery disease.
- Investigated the survival benefit of total arterial revascularization (TAR) in diabetic patients undergoing CABG.
Purpose of the Study:
- To determine if total arterial revascularization (TAR) provides an additional survival advantage for diabetic patients undergoing coronary artery bypass graft surgery (CABG).
Main Methods:
- A retrospective analysis of 63,592 cases from an Australian cardiac surgical database.
- Identified 11,642 diabetic patients undergoing first-time isolated CABG between 2001 and 2012.
- Used propensity matching to create 6,232 pairs of diabetic patients who did or did not receive TAR, linking data to the National Death Index.
Main Results:
- Perioperative mortality was similar between TAR and non-TAR groups (1.2% vs. 1.4%, p=0.506).
- Late mortality was significantly lower in the TAR group (10.2%) compared to the non-TAR group (12.2%, p=0.041).
- Kaplan-Meier survival at 1, 5, and 10 years was higher for the TAR group (96.2%, 88.9%, 82.2%) versus non-TAR (95.4%, 87.5%, 78.3%; log rank, p=0.036).
Conclusions:
- Total arterial revascularization (TAR) offers a significant long-term survival benefit for diabetic patients undergoing CABG.
- This benefit is achieved with equivalent perioperative mortality rates compared to non-TAR approaches.
- TAR should be considered for diabetic patients requiring CABG to improve long-term prognostic outcomes.
Background:
Recent large randomized trials and metaanalyses have shown that, for patients with diabetes mellitus and advanced coronary artery disease, coronary artery bypass graft surgery (CABG) was superior to percutaneous intervention. We investigated whether total arterial revascularization (TAR) conferred an additional survival advantage for diabetic patients having CABG.
Methods:
We reviewed 63,592 cases from an audited, collaborative Australian cardiac surgical database. A total of 34,181 patients undergoing first time isolated CABG from 2001 to 2012 were identified. Of the 34,181, 11,642 (34.1%) were diabetic patients, and TAR was performed in 12,271 of 34,181 (35.9%). Of the 11,642 diabetic patients, TAR was performed in 3,795 (32.6%) and non-TAR in 7,847 (67.4%). Propensity matching resulted in 6,232 matched pairs of patients who did and patients who did not have TAR. Data were linked to the National Death Index.
Results:
In the propensity matched sample, of 6,232 diabetic patients, 2,017 (32.4%) underwent TAR and 1,967 (31.6%) did not (p = 0.337). Mean follow-up was 4.9 years. Perioperative mortality, including 30-day mortality, was similar: 1.2% (24 of 2,017) for TAR and 1.4% (28 of 1,967) for non-TAR (p = 0.506). Late mortality was less among diabetic patients who underwent TAR, 10.2% (205 of 2,017), than no TAR, 12.2% (240 of 1,967; p = 0.041). Kaplan-Meier survival for the diabetic TAR group at 1, 5, and 10 years was 96.2%, 88.9%, and 82.2%, respectively, versus 95.4%, 87.5%, and 78.3% for the diabetic non-TAR group (log rank, p = 0.036).
Conclusions:
In a large propensity matched cohort of patients having CABG, TAR demonstrated further long-term prognostic benefit for diabetic patients, in the context of equivalent perioperative mortality.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease V: Postoperative Nursing Management
Acute Coronary Syndrome IV: Interprofessional Care
Atherosclerosis III: Management
